Indication
Rhinitis
Rhinitis is an inflammatory or dysfunctional disorder of the nasal mucosa affecting the upper respiratory tract in pediatric and adult populations. Read more about Rhinitis
323 drugs 81 manufacturers
Drugs that treat it
Common Rhinitis therapies.
TUSSIN CF (guaifenesin/dextromethorphan HBr/phenylephrine)
TUSSIN CF (guaifenesin/dextromethorphan HBr/phenylephrine)
GILPHEX TR (guaifenesin/phenylephrine HCl)
GILTUSS TR (guaifenesin/dextromethorphan HBr/phenylephrine)
CERTUSS-D (pseudoephedrine HCl/chlophedianol HCl/guaifenesin)
COUGH & COLD MUCUS RELIEF CF (guaifenesin/dextromethorphan HBr/phenylephrine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRhinitis is an inflammatory or dysfunctional disorder of the nasal mucosa affecting the upper respiratory tract in pediatric and adult populations.
Clinically, it is characterized by symptoms such as rhinorrhea, nasal congestion, sneezing, postnasal drip, and nasal pruritus.
Pathophysiologically, it encompasses diverse etiologies broadly categorized into allergic rhinitis—driven by immunoglobulin E–mediated hypersensitivity and inflammatory mediator release—as well as infectious and nonallergic phenotypes triggered by autonomic dysfunction, environmental irritants, medications, or hormonal changes.
- nih.gov
Rhinitis is an inflammatory or dysfunctional disorder of the nasal mucosa affecting the upper respiratory tract in pediatric and adult populations Clinically, it is characterized by symptoms such as rhinorrhea, nasal congestion, sneezing, postnasal drip, and nasal pruritus Pathophysiologically, it encompasses diverse etiologies broadly categorized into allergic rhinitis—driven by immunoglobulin E–mediated hypersensitivity and inflammatory mediator release—as well as infectious and nonallergic ph...
- nih.gov
Rhinitis is an inflammatory or dysfunctional disorder of the nasal mucosa affecting the upper respiratory tract in pediatric and adult populations
- nih.gov
Rhinitis is an inflammatory or dysfunctional disorder of the nasal mucosa affecting the upper respiratory tract in pediatric and adult populations Pathophysiologically, it encompasses diverse etiologies broadly categorized into allergic rhinitis—driven by immunoglobulin E–mediated hypersensitivity and inflammatory mediator release—as well as infectious and nonallergic phenotypes triggered by autonomic dysfunction, environmental irritants, medications, or hormonal changes
- nih.gov
Clinically, it is characterized by symptoms such as rhinorrhea, nasal congestion, sneezing, postnasal drip, and nasal pruritus
- nih.gov
Pathophysiologically, it encompasses diverse etiologies broadly categorized into allergic rhinitis—driven by immunoglobulin E–mediated hypersensitivity and inflammatory mediator release—as well as infectious and nonallergic phenotypes triggered by autonomic dysfunction, environmental irritants, medications, or hormonal changes
Personalize your experience
Follow Rhinitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.